Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF

Loncar Cancer Immunotherapy ETF (CNCR) ETF

Today's Latest Price: $22.29 USD

0.19 (-0.85%)

Updated Feb 27 12:39pm

Add CNCR to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 35 in Health & Biotech ETFs

See all "A" rated Strong Buy stocks

CNCR Daily Price Range
CNCR 52-Week Price Range

CNCR Stock Price Chart More Charts

CNCR Price/Volume Stats

Current price $22.29 52-week high $24.57
Prev. close $22.48 52-week low $17.82
Day low $21.89 Volume 6,059
Day high $22.76 Avg. volume 14,084
50-day MA $22.91 Dividend yield 0.00001%
200-day MA $21.05

Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio

The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.


Issuer Exchange Traded Concepts
Expense Ratio 0.79%
Underlying Index Loncar Cancer Immunotherapy Index
Asset Class Equity
Sector Health & Biotech ETFs
Assets Under Management (AUM) 36.18M
Net Asset Value (NAV) $0.00
Options? Yes
Total Holdings 27

CNCR Price Returns

1-mo 1.04%
3-mo -4.99%
6-mo 14.43%
1-year 0.77%
3-year -3.51%
5-year N/A
YTD -4.91%
2019 24.22%
2018 -20.65%
2017 13.61%
2016 -25.63%
2015 N/A

CNCR Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CNCR Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6242 seconds.